{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Digestive+Disease&page=36", "query": { "condition": "Digestive Disease", "page": 36 }, "page_size": 10 }, "pagination": { "page": 36, "page_size": 10, "total_count": 14943, "total_pages": 1495, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Digestive+Disease&page=37&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Digestive+Disease&page=35&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-28T14:26:35.985Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT01144936", "title": "Study of VX-985 in Subjects With Chronic Hepatitis C", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Chronic Hepatitis C" ], "interventions": [ { "name": "VX-985 or matching placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Vertex Pharmaceuticals Incorporated", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "64 Years", "sex": "ALL", "summary": "18 Years to 64 Years" }, "enrollment_count": 21, "start_date": "2010-06", "completion_date": "2010-10", "has_results": false, "last_update_posted_date": "2011-03-09", "last_synced_at": "2026-10-28T14:26:35.985Z", "location_count": 3, "location_summary": "Overland Park, Kansas • Baltimore, Maryland • Tacoma, Washington", "locations": [ { "city": "Overland Park", "state": "Kansas" }, { "city": "Baltimore", "state": "Maryland" }, { "city": "Tacoma", "state": "Washington" } ], "official_url": "https://clinicaltrials.gov/study/NCT01144936" }, { "nct_id": "NCT05546411", "title": "A Trial of NIS793 With FOLFIRINOX in Pancreatic Cancer", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Pancreatic Cancer", "Resectable Pancreatic Cancer", "Borderline Resectable Pancreatic Adenocarcinoma", "Pancreatic Adenocarcinoma" ], "interventions": [ { "name": "mFOLFIRINOX", "type": "DRUG" }, { "name": "5-Fluorouracil (5-FU)", "type": "DRUG" }, { "name": "Oxaliplatin", "type": "DRUG" }, { "name": "Irinotecan", "type": "DRUG" }, { "name": "Leucovorin", "type": "DRUG" }, { "name": "NIS793", "type": "DRUG" }, { "name": "Chemoradiation", "type": "RADIATION" }, { "name": "Surgery", "type": "PROCEDURE" } ], "intervention_types": [ "DRUG", "RADIATION", "PROCEDURE" ], "sponsor": "Kimberly Perez, MD", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 8, "start_date": "2023-01-06", "completion_date": "2023-10-13", "has_results": true, "last_update_posted_date": "2024-12-17", "last_synced_at": "2026-10-28T14:26:35.985Z", "location_count": 2, "location_summary": "Boston, Massachusetts", "locations": [ { "city": "Boston", "state": "Massachusetts" }, { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT05546411" }, { "nct_id": "NCT07845487", "title": "A Trial to Investigate PALI-2108 Versus Placebo in Participants With Moderately to Severely Active Ulcerative Colitis", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Ulcerative Colitis (UC)", "Severe Ulcerative Colitis", "Moderate Ulcerative Colitis" ], "interventions": [ { "name": "PALI-2108", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Palisade Bio", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 204, "start_date": "2026-08-28", "completion_date": "2028-06", "has_results": false, "last_update_posted_date": "2026-10-21", "last_synced_at": "2026-10-28T14:26:35.985Z", "location_count": 30, "location_summary": "Sun City, Arizona • San Diego, California • Bristol, Connecticut + 27 more", "locations": [ { "city": "Sun City", "state": "Arizona" }, { "city": "San Diego", "state": "California" }, { "city": "Bristol", "state": "Connecticut" }, { "city": "Orlando", "state": "Florida" }, { "city": "Des Plaines", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT07845487" }, { "nct_id": "NCT05776914", "title": "Fecal Microbiota Transplantation for IBS", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Irritable Bowel Syndrome", "Diarrhea" ], "interventions": [ { "name": "Donor Fecal Microbiota Transplantation", "type": "BIOLOGICAL" }, { "name": "Autologous Fecal Microbiota Transplantation", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Madhusudan (Madhu) Grover, MBBS", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "70 Years", "sex": "FEMALE", "summary": "18 Years to 70 Years · Female only" }, "enrollment_count": 43, "start_date": "2024-04-15", "completion_date": "2027-06-26", "has_results": false, "last_update_posted_date": "2026-05-08", "last_synced_at": "2026-10-28T14:26:35.985Z", "location_count": 1, "location_summary": "Rochester, Minnesota", "locations": [ { "city": "Rochester", "state": "Minnesota" } ], "official_url": "https://clinicaltrials.gov/study/NCT05776914" }, { "nct_id": "NCT02431312", "title": "Phase I Study of INO-1800 With or Without INO-9112 + EP in Chronic Hepatitis B Subjects", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Hepatitis B" ], "interventions": [ { "name": "INO-1800", "type": "BIOLOGICAL" }, { "name": "INO-9112", "type": "BIOLOGICAL" }, { "name": "Nucleos(t)ide Analogue Treatment", "type": "DRUG" } ], "intervention_types": [ "BIOLOGICAL", "DRUG" ], "sponsor": "Inovio Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 90, "start_date": "2015-01-12", "completion_date": "2018-05-22", "has_results": false, "last_update_posted_date": "2019-10-15", "last_synced_at": "2026-10-28T14:26:35.985Z", "location_count": 7, "location_summary": "San Diego, California • Miami, Florida • Manhasset, New York + 4 more", "locations": [ { "city": "San Diego", "state": "California" }, { "city": "Miami", "state": "Florida" }, { "city": "Manhasset", "state": "New York" }, { "city": "New York", "state": "New York" }, { "city": "Cincinnati", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT02431312" }, { "nct_id": "NCT00321100", "title": "Combination of Cetuximab, Capecitabine, and Oxaliplatin With or Without Bevacizumab", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Colorectal Neoplasms" ], "interventions": [ { "name": "bevacizumab", "type": "DRUG" }, { "name": "cetuximab", "type": "DRUG" }, { "name": "Oxaliplatin", "type": "DRUG" }, { "name": "Capecitabine", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Fox Chase Cancer Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 23, "start_date": "2006-04-12", "completion_date": "2013-12-18", "has_results": true, "last_update_posted_date": "2022-01-12", "last_synced_at": "2026-10-28T14:26:35.985Z", "location_count": 1, "location_summary": "Philadelphia, Pennsylvania", "locations": [ { "city": "Philadelphia", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT00321100" }, { "nct_id": "NCT00547144", "title": "Phase I/II Intratumoral DC Immunotherapy With Gemcitabine & XRT in Unresectable Pancreatic Cancer", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Pancreatic Cancer" ], "interventions": [ { "name": "Gemcitabine", "type": "DRUG" }, { "name": "Dendritic Cell Immunotherapy", "type": "PROCEDURE" } ], "intervention_types": [ "DRUG", "PROCEDURE" ], "sponsor": "George Albert Fisher", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 2, "start_date": "2005-10", "completion_date": "2008-04", "has_results": false, "last_update_posted_date": "2012-11-08", "last_synced_at": "2026-10-28T14:26:35.985Z", "location_count": 1, "location_summary": "Stanford, California", "locations": [ { "city": "Stanford", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00547144" }, { "nct_id": "NCT05050721", "title": "Natural History of Non Alcoholic Fatty Liver Disease and Predictors of Advanced Fibrosis", "overall_status": "WITHDRAWN", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Non-alcoholic Steatohepatitis (NASH)" ], "interventions": [ { "name": "CT imaging", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "Methodist Health System", "sponsor_class": "OTHER", "healthy_volunteers": null, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 0, "start_date": "2019-10-04", "completion_date": "2021-09-10", "has_results": false, "last_update_posted_date": "2021-12-13", "last_synced_at": "2026-10-28T14:26:35.985Z", "location_count": 1, "location_summary": "Irving, Texas", "locations": [ { "city": "Irving", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT05050721" }, { "nct_id": "NCT07752407", "title": "A Study to Evaluate the Efficacy and Safety of Vonoprazan 10 mg Compared to Placebo for Relief of Episodic Heartburn in Participants With Symptomatic Non-Erosive Gastroesophageal Reflux Disease Through 24 Weeks", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Symptomatic Non-erosive Gastroesophageal Reflux Disease" ], "interventions": [ { "name": "Vonoprazan", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Phathom Pharmaceuticals, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 500, "start_date": "2026-09-25", "completion_date": "2028-01-19", "has_results": false, "last_update_posted_date": "2026-10-07", "last_synced_at": "2026-10-28T14:26:35.985Z", "location_count": 1, "location_summary": "Mentor, Ohio", "locations": [ { "city": "Mentor", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT07752407" }, { "nct_id": "NCT00728936", "title": "Placebo-controlled, Dose-escalation Study of the Safety of IMO-2125 (Immunomodulatory Oligonucleotide) in Hepatitis C-infected Patients", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Hepatitis C" ], "interventions": [ { "name": "IMO-2125", "type": "DRUG" }, { "name": "Saline placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Idera Pharmaceuticals, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 58, "start_date": "2007-09", "completion_date": "2010-05", "has_results": true, "last_update_posted_date": "2019-02-15", "last_synced_at": "2026-10-28T14:26:35.985Z", "location_count": 6, "location_summary": "Aurora, Colorado • Marietta, Georgia • Novi, Michigan + 3 more", "locations": [ { "city": "Aurora", "state": "Colorado" }, { "city": "Marietta", "state": "Georgia" }, { "city": "Novi", "state": "Michigan" }, { "city": "Durham", "state": "North Carolina" }, { "city": "Dallas", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT00728936" } ] }